MSB 7.69% $1.19 mesoblast limited

Joining an on-going phase III trial for Covid/ards being run in...

  1. 1,886 Posts.
    lightbulb Created with Sketch. 2456

    Joining an on-going phase III trial for Covid/ards being run in the US mid-stream - but MSB think it isn't price sensitive?

    If we get successful results this month from the Covid/Ards trails, given Australia is part of the trial now, one would assume the pathway to this being approved in Australia is a lot easier and quicker - so potentially two immediate markets - but MSB don't think this is price sensitive?

    MSB may have the best medical treatments in the world - I hope when the succeed they get some decent corporate communications people.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.